Heartseed, Inc.
JPX: 219A.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Keiichi Fukuda
- Employees
- 39
- Headquarters
- Tokyo, Japan
- IPO year
- 2024
- Market cap
- ¥41.3B
- Website
- http://www.heartseed.jp
Loading 219A…
Loading profile data…Frequently asked questions about 219A
What does Heartseed, Inc. (219A.T) do?
Heartseed, Inc. engages in the provision of cardiac regenerative medicine. The company was founded by Keiichi Fukuda, Takumi Akiyama, Toshiharu Furukawa and Yutaro Kasai on November 30, 2015 and is headquartered in Tokyo, Japan.
Where does 219A.T trade?
Heartseed, Inc. (219A.T) trades on the Tokyo Stock Exchange.
What sector is 219A.T in?
Heartseed, Inc. (219A.T) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Heartseed, Inc.?
Keiichi Fukuda is the chief executive officer of Heartseed, Inc. (219A.T).
Where is Heartseed, Inc. headquartered?
Heartseed, Inc. is headquartered in Japan.
Does 219A.T pay a dividend?
Heartseed, Inc. (219A.T) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 219A.T go public?
Heartseed, Inc. (219A.T) completed its initial public offering in 2024.